The F0stamatinib Disodium Hexahydrat, cataloged under National Stock Number 6505-01-692-3286, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Rigel Pharmaceuticals Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-692-3286 |
| Primary Part Number | NDC71332-0002-01 |
| Item Name | F0stamatinib Disodium Hexahydrat |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Rigel Pharmaceuticals Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC71332-0002-01 PRIMARY | Rigel Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| TAVALISSE | 5/1 Secondary reference Rigel Pharmaceuticals Inc |
| 1586573 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM206627 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-692-3286 is a F0stamatinib Disodium Hexahydrat, manufactured by Rigel Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-692-3286 has 1 manufacturer part number on file: NDC71332-0002-01 (Rigel Pharmaceuticals Inc).
Key specifications for NDC71332-0002-01: Special Features: A KINASE INHIBITOR INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT; 150 MG TABLETS; 60 TABLETS; STORE AT ROOM TEMPERATURE, 20 C TO 25 C (68 F TO 77 F); EXCURSIONS PERMITTED BETWEEN 15 C TO 30 C (59 F TO 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE). DO NOT REMOVE DESICCANTS; FOR ADULTS ONLY (AT LEAST 18 YEARS OF AGE).; Part Name Assigned by Controlling Agency: FOSTAMATINIB TABLETS, 150 MG, 60S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.